# FDA Inspection 1165854 - Invitrx Therapeutics Inc. - March 22, 2022

Source: https://www.keypedia.com/records/fda_inspections/invitrx-therapeutics-inc/6d1c02ea-ed52-43f5-be1c-143b4644fade
Source feed: FDA_Inspections

> FDA Inspection 1165854 for Invitrx Therapeutics Inc. on March 22, 2022. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1165854
- Company Name: Invitrx Therapeutics Inc.
- Inspection Date: 2022-03-22
- Classification: Official Action Indicated (OAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1265382 - 2025-04-30](https://www.keypedia.com/records/fda_inspections/invitrx-therapeutics-inc/08b1cfe9-b127-4584-818e-f5554d7b3a3d)
- [FDA Inspection 1101970 - 2019-09-13](https://www.keypedia.com/records/fda_inspections/invitrx-therapeutics-inc/fbf83fa8-57b3-4e55-9b00-0ced9ec29fe1)
- [FDA Inspection 1084910 - 2019-04-03](https://www.keypedia.com/records/fda_inspections/invitrx-therapeutics-inc/20c71ece-e5a6-4774-b48c-b6c6ac511713)

Company: https://www.keypedia.com/companies/invitrx-therapeutics-inc/56153bdd-2935-4184-99ff-28af39f1fc61

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d